Epirubicin/paclitaxel/carboplatin (TEC) vs paclitaxel/carboplatin (TC) in first-line treatment of ovarian cancer FIGO stages IIB–IV. Results of a randomized AGO-GINECO GCIG Intergroup phase III trial
Titel:
Epirubicin/paclitaxel/carboplatin (TEC) vs paclitaxel/carboplatin (TC) in first-line treatment of ovarian cancer FIGO stages IIB–IV. Results of a randomized AGO-GINECO GCIG Intergroup phase III trial
Auteur:
Pujade-Lauraine, E. Du Bois, A. Goupil, A. Rochon, J. Möbus, V. Weber, B. Olbricht, S. Nitz, U. Warm, M. Richter, B.